-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
e-Learning & Training
Specific training and best practice modules for cardiovascular physicians and surgeons, and medical practitioners.
-
Expert Reviews
Independent summary information selected and analysed by our expert Editorial Board.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists,scientists and medical practitioners.
Upcoming Events
9
May
18
Oct
18
Oct
22
Oct
28
Oct
IDSS 2018 – Tel Aviv, Israel
Conferences 28 Oct 2018
29
Nov
CVCT 2018 – Washington, USA
Conferences 29 Nov 2018
Highlights
The latest reviews, resources and expert analysis from our website.
Expert Opinions: First in Class ARNI, Valsartan/Sacubitril as a New Treatment of Chronic HFrEF
Posted on May 24, 2018
Expert Reviews: Antiplatelet Therapy In Acute Coronary Syndrome
Posted on October 10, 2018
Clinical Trials: Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness (MARINER)
Posted on September 13, 2018
Webinars and e-Learning: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors
Posted on July 12, 2017
newsfeed
History of cardiotoxicity, cancer treatment linked to congestive HF during, after pregnancy
Posted on October 15, 2018
Women with a prior history of cardiotoxicity previously treated for cancer with radiation or chemotherapy had elevated odds of developing clinical congestive... more
Multidisciplinary approach to CLI care may confer fewer amputations
Posted on October 15, 2018
SAN DIEGO — An effective treatment option for patients with critical limb ischemia may involve a multidisciplinary approach, according to a presentation... more
COMPARE-ABSORB: BVS noninferior to EES for TLF in high-risk patients
Posted on October 15, 2018
SAN DIEGO — In a population of high-risk patients, a bioresorbable vascular scaffold was noninferior to an everolimus-eluting stent for target lesion... more
Death from sepsis common, possibly preventable in patients with chronic HFrEF
Posted on October 15, 2018
Sepsis is a leading cause of death in people with chronic HF with reduced left ventricular ejection fraction and may be preventable,... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Koji Hasegawa
President
Affiliations/Memberships Director, Division of Translational Research, Kyoto Medical Center Leader, Cardiovascular Clinical Research Network, National Hospital Organization Visiting Professor, University of Shizuoka (more…) more
-
Augusto Gallino
President Elect
Affiliations/Memberships University of Zurich Zurich Switzerland Research interests Atherosclerosis ACS CV Imaging Antithrombotic TX Transplantation President Elect, International Society of Cardiovascular Pharmacotherapy more
-
Thomas Kahan
Treasurer
Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine Karolinska Institutet Senior Consultant in Cardiology Department of (more…) more
-
Dennis Cokkinos
Secretary
Affiliations/Memberships Professor of Cardiology Emeritus, University of Athens Honorary Director of Onassis Cardiac Surgery Center Head of Cardiovascular Research Division, Biomedical Research Foundation Academy of Athens more
-
Felipe Martínez
ISCP Executive Committee
Affiliations/Memberships Emeritus Professor of Medicine Cordoba National University Director Instituto DAMIC-Fundación Rusculleda Córdoba Argentina Fellow of the European Society of Cardiology (FESC) (more…) more
-
Gheorghe-Andrei Dan
ISCP Executive Committee
Affiliations Professor of Cardiology and Internal Medicine Head of Internal Medicine Clinic Head of Cardiology Department Senior Researcher 1st dgr Colentina University Hospital Medicine Faculty Carol Davila (more…) more
-
Antoni Martínez-Rubio
ISCP Executive Committee
Affiliations/Memberships Department of Cardiology University Hospital Sabadell Autonomous University of Barcelona Barcelona Spain International Society of Cardiovascular Pharmacotherapy Research interests (more…) more
-
Juan Carlos Kaski
ISCP Executive Committee
Affiliations/Memberships Professor of Cardiovascular Science St George's University of London London UK Research interests Coronary artery disease Microvascular angina Cardiac biomarkers Coronary artery spasm Inflammation more
Featured Review
Antiplatelet Therapy In Acute Coronary Syndrome
Kerry Layne, Albert Ferro
Acute coronary syndrome (ACS) is a term used to encompass unstable angina (UA) and myocardial infarction (MI) with or without electrocardiographic (ECG) evidence of ST-segment elevation. Antiplatelet therapy has formed the backbone of ACS management for decades and the drug class continues to evolve as novel agents with increasingly...
